Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool Publisher Pubmed



Sammallahti H^{1, 2} ; Sarhadi VK³ ; Kokkola A² ; Ghanbari R⁴ ; Rezasoltani S⁵ ; Aghdaei HA⁶ ; Puolakkainen P² ; Knuutila S¹ Show Affiliations
Source: Biomolecules Published:2022

Abstract

Pancreatic cancer (PC) is an aggressive malignancy with a dismal prognosis. To improve patient survival, the development of screening methods for early diagnosis is pivotal. Oncogenomic alterations present in tumor tissue are a suitable target for non-invasive screening efforts, as they can be detected in tumor-derived cells, cell-free nucleic acids, and extracellular vesicles, which are present in several body fluids. Since stool is an easily accessible source, which enables convenient and cost-effective sampling, it could be utilized for the screening of these traces. Herein, we explore the various oncogenomic changes that have been detected in PC tissue, such as chromosomal aberrations, mutations in driver genes, epigenetic alterations, and differentially expressed non-coding RNA. In addition, we briefly look into the role of altered gut microbiota in PC and their possible associations with oncogenomic changes. We also review the findings of genomic alterations in stool of PC patients, and the potentials and challenges of their future use for the development of stool screening tools, including the possible combination of genomic and microbiota markers. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.